LEUCEMIA DE CÉLULAS MASTOCITÁRIAS: RELATO DE CASO DE UMA DOENÇA POUCO CONHECIDA

Autor: Zenero, PL, Lima, GG, Elias, MDV, Almeida, ICTS, Carvalho, LV, Marchi, LL, Velloso, E, Rocha, VG

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S161-S162

Up-Front ASCT Overcomes the Survival Benefit Provided by HDAC-Based Induction Regimens in Mantle Cell Lymphoma: Data from a Real-Life and Long-Term Cohort.

Autor: de Pádua Covas Lage LA; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil., Elias MDV; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil., Reichert CO; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil., Culler HF; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil., de Freitas FA; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil., de Oliveira Costa R; Department of Hematology and Hemotherapy, Faculty of Medical Sciences of Santos (FCMS), Santos 01238-010, SP, Brazil.; Hospital Alemão Osvaldo Cruz (HAOC), São Paulo 01323-020, SP, Brazil., Rocha V; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil.; Fundação Pró-Sangue, Blood Bank of São Paulo, São Paulo 05403-000, SP, Brazil.; Department of Hematology, Churchill Hospital, Oxford University, Oxford OX3 7LE, UK., da Siqueira SAC; Department of Pathology, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil., Pereira J; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Faculty of Medicine, University of São Paulo (USP), São Paulo 05508-080, SP, Brazil.; Hospital Alemão Osvaldo Cruz (HAOC), São Paulo 01323-020, SP, Brazil.

Publikováno v: Cancers [Cancers (Basel)] 2023 Sep 28; Vol. 15 (19). Date of Electronic Publication: 2023 Sep 28.